CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Monitoring and Managing CRS, ICANS, and Infections With Bispecifics]]>

bispecificsNeutral
AI Analysis

Summary

Dr. Ralph V. Boccia discusses clinical management strategies for patients receiving bispecific antibodies, including remote monitoring, ICE scoring, cytokine release syndrome prophylaxis, and intravenous immunoglobulin strategies.

Importance:2/10
Sentiment:
0.00
bispecific antibodiescytokine release syndromeCRSICANSmonitoringsafety managementclinical practice

Read the original article

Published by Cancer Network on October 12, 2026 2:00 PM

Read Original